The hypertriglyceridemic waist phenotype and metabolic syndrome by differing criteria in type 2 diabetic patients and their relation to lipids and blood glucose control

Endokrynologia Polska

Volumn 62, Issue 4, 2011, Pages 316-323

  Radenković, Saša P ^a,b   Kocić, Radivoj D ^a,b   Pešić, Milica M ^a,b   Dimić, Dragan N ^a,b   Velojić Golubović, Milena D ^a,b   Radojković, Danijela B ^a,b   Čirić, Vojislav M ^a  

^a Clinical Centre Nis   (Serbia)

^b UNIVERSITY OF NI   (Serbia)

Author keywords

Blood glucose control; Blood lipids; Hypertriglyceridemic waist; Metabolic syndrome; Type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN;

ABDOMINAL OBESITY; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

AGED; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHENOTYPE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEX FACTORS; STATISTICS AS TOPIC; WAIST CIRCUMFERENCE;

EID: 80052555412     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Cameron A.J., Shaw J.E., Zimmet P.Z. The metabolic syndrome: Prevalence in worldwide populations. Endocrinol Metab Clin N Am 2004; 33: 351-376.
2. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005; 365: 1415-1428. (Pubitemid 40523737)
3. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553. (Pubitemid 28319935)
4. Balkau B., Charles M.A. Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999; 16: 442-443.
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
6. Hunt K.J., Resendez R.G., Williams K., Haffner S.M., Stern M.P. San Antonio Heart Study. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004; 110: 1251-1257. (Pubitemid 39202341)
7. Grundy S.M., Cleeman J.I., Daniels S.R. et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752. (Pubitemid 41532612)
8. Alberti K.G., Zimmet P., Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - A new worldwide definition. Lancet 2005; 366: 1059-1062. (Pubitemid 41338752)
9. Balkau B., Deanfield J.E., Després J.P. et al. International Day for the Evaluation of Abdominal Obesity (IDEA): A study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 2007; 116: 1942-1951. (Pubitemid 350287090)
10. Carr D.B., Utzschneider K.M., Hull R.L. et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004; 53: 2087-2094. (Pubitemid 38970759)
11. Saely C.H., Koch L., Schmid F. et al. Adult Treatment Panel III 2001, but not International Diabetes Federation 2005 criteria of the metabolic syndrome, predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care 2006; 29: 901-907. (Pubitemid 44115314)
12. Tong P.C., Kong A.P., So W.Y. et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care 2007; 30: 1206-1211. (Pubitemid 46684649)
13. McNeill A.M., Rosamond W.D., Girman C.J. et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005; 28: 385-390. (Pubitemid 40170944)
14. Gami A.S., Witt B.J., Howard D.E. et al. Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49: 403-414. (Pubitemid 46135879)
15. Lamarche B., Tchernof A., Mauriège P. et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 1998; 279: 1955-1961. (Pubitemid 28298273)
16. Lemieux I., Pascot A., Couillard C. et al. Hypertriglyceridemic waist. A marker of the atherogenic metabolic triad (hyperinsulinemia, hyperapolipoprotein B, small, dense LDL) in men? Circulation 2000; 102: 179-184. (Pubitemid 30451774)
17. Zimmet P., Alberti K.G., Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787. (Pubitemid 34000780)
18. Ford E.S. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005; 28: 2745-2749. (Pubitemid 43951170)
19. Li W.J., Xue H., Sun K. et al. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria. Chin Med J 2008; 121: 1532-1536.
20. Welin L., Adlerberth A., Caidahl K. et al. Prevalence of cardiovascular risk factors and the metabolic syndrome in middle-aged men and women in Gothenburg, Sweden. BMC Public Health 2008; 8: 403.
21. De Simone G., Devereux R.B., Chinali M. et al. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: The Strong Heart Study. Diabetes Care 2007; 30: 1851-1856. (Pubitemid 47036363)
22. Gu D., Reynolds K., Wu X. et al. Inter ASIA Collaborative Group, Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005; 365: 1398-1405. (Pubitemid 40523734)
23. Harzallah F., Alberti H., Khalifa F.B. The metabolic syndrome in an Arab population: A first look at the new International Diabetes Federation criteria. Diabetic Medicine 2006; 23: 441-444.
24. Hadaegh F., Zabetian A., Tohidi M., Ghasemi A., Sheikholeslami F., Azizi F. Prevalence of metabolic syndrome by the Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions and their association with coronary heart disease in an elderly Iranian population. Ann Acad Med Singapore 2009; 38: 142-149.
25. Lemieux I., Alméras N., Mauriège P. et al. Prevalence of 'hypertriglyceridemic waist' in men who participated in the Quebec Health Survey: Association with atherogenic and diabetogenic metabolic risk factors. Can J Cardiol 2002; 18: 725-732. (Pubitemid 34873842)
26. Laakso M., Pyörälä K., Voutilainen E., Marniemi J. Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects. Am J Epidemiol 1987; 125: 611-621. (Pubitemid 17047134)
27. LaMonte M.J., Ainsworth B.E., DuBose K.D. et al. The hypertriglyceridemic waist phenotype among women. Atherosclerosis 2003; 171: 123-130. (Pubitemid 37464637)
28. Skilton M.R., Moulin P., Serusclat A., Nony P., Bonnet F. A comparison of the NCEP-ATPIII, IDF and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: Evidence for sex-specific differences. Atherosclerosis 2007; 190: 416-422. (Pubitemid 46074033)
29. Koutsovasilis A., Protopsaltis J., Triposkiadis F. et al. Comparative performance of three metabolic syndrome definitions in the prediction of acute coronary syndrome. Intern Med 2009; 48: 179-187.
30. Kasai T., Miyauchi K., Kurata T. et al. Prognostic value of the metabolic syndrome for long-term outcomes in patients undergoing percutaneous coronary intervention. Circ J 2006; 70: 1531-1537. (Pubitemid 44819865)
31. Blackburn P., Lemieux I., Alméras N. et al. The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program - Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile. Metabolism 2009; 58: 1123-1130.
32. St-Pierre J., Lemieux I., Perron P. et al. Relation of the "hypertriglyceridemic waist" phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus. Am J Cardiol 2007; 99: 369-373. (Pubitemid 46157216)
33. Gazi I.F., Filippatos T.D., Tsimihodimos V. et al. The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol. Lipids 2006; 41: 647-654. (Pubitemid 44547679)